|
1
|
Ottini L, Palli D, Rizzo S, Federico M,
Bazan V and Russo A: Male breast cancer. Crit Rev Oncol Hematol.
73:141–155. 2010. View Article : Google Scholar
|
|
2
|
Mohamad HB and Apffelstaedt JP: Counseling
for male BRCA mutation carriers: a review. Breast. 17:441–450.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Erkko H, Dowty JG, Nikkilä J, Syrjäkoski
K, Mannermaa A, Pylkäs K, Southey MC, Holli K, Kallioniemi A,
Jukkola-Vuorinen A, Kataja V, Kosma VM, Xia B, Livingston DM,
Winqvist R and Hopper JL: Penetrance analysis of the PALB2
c.1592delT Founder mutation. Clin Cancer Res. 14:4667–4671. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Foulkes WD, Ghadirian P, Akbari MR, Hamel
N, Giroux S, Sabbaghian N, Darnel A, Royer R, Poll A, Fafard E,
Robidoux A, Martin G, Bismar TA, Tischkowitz M, Rousseau F and
Narod SA: Identification of a novel truncating PALB2 mutation and
analysis of its contribution to early-onset breast cancer in
French-Canadian women. Breast Cancer Res. 9:R832007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jones S, Hruban RH, Kamiyama M, et al:
Exomic sequencing identifies PALB2 as a pancreatic cancer
susceptibility gene. Science. 324:2172009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hofstatter EW, Domchek SM, Miron A, Garber
J, Wang M, Componeschi K, Boghossian L, Mitron PL, Nathanson KL and
Tung N: PALB2 mutations in familial breast and pancreatic cancer.
Fam Cancer. 10:225–231. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Slater EP, Langer P, Niemczyk E, Strauch
K, Butler J, Habbe N, Neoptolemos JP, Greenhalf W and Bartsch DK:
PALB2 mutations in European familial pancreatic cancer families.
Clin Genet. 78:490–494. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Peterlongo P, Catucci I, Pasquini G,
Verderio P, Peissel B, Barile M, Varesco L, Riboni M, Fortuzzi S,
Manoukian S and Radice P: PALB2 germline mutations in familial
breast cancer cases with personal and family history of pancreatic
cancer. Breast Cancer Res Treat. 126:825–828. 2011. View Article : Google Scholar
|
|
9
|
Tischkowitz M, Sabbaghian N, Ray AM, Lange
EM, Foulkes WD and Cooney KA: Analysis of the gene coding for the
BRCA2-interacting protein PALB2 in hereditary prostate cancer.
Prostate. 68:675–678. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pakkanen S, Wahlfors T, Siltanen S,
Patrikainen M, Matikainen MP, Tammela TL and Schleutker J: PALB2
variants in hereditary and unselected Finnish prostate cancer
cases. J Negat Results Biomed. 8:122009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
García MJ, Fernández V, Osorio A, Barroso
A, Llort G, Lázaro C, Blanco I, Caldés T, de la Hoya M, Ramón Y,
Cajal T, Alonso C, Tejada MI, San Román C, Robles-Díaz L, Urioste M
and Benítez J: Analysis of FANCB and FANCN/PALB2 Fanconi anemia
genes in BRCA1/2-negative Spanish breast cancer families. Breast
Cancer Res Treat. 113:545–1551. 2009. View Article : Google Scholar
|
|
12
|
Casadei S, Norquist BM, Walsh T, Stray S,
Mandell JB, Lee MK, Stamatoyannopoulos JA and King MC: Contribution
of inherited mutations in the BRCA2-interacting protein PALB2 to
familial breast cancer. Cancer Res. 71:2222–2229. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ding YC, Steele L, Kuan CJ, Greilac S and
Neuhausen SL: Mutations in BRCA2 and PALB2 in male breast cancer
cases from the United States. Breast Cancer Res Treat. 6:771–778.
2011. View Article : Google Scholar
|
|
14
|
Adank MA, van Mil SE, Gille JJ, Waisfisz Q
and Meijers-Heijboer H: PALB2 analysis in BRCA2-like families.
Breast Cancer Res Treat. 127:357–362. 2011. View Article : Google Scholar
|
|
15
|
Sauty de Chalon A, Teo Z, Park DJ, Odefrey
FA, Hopper JL and Southey MC: Are PALB2 mutations associated with
increased risk of male breast cancer? Breast Cancer Res Treat.
121:253–255. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Silvestri V, Rizzolo P, Zanna I, Falchetti
M, Masala G, Bianchi S, Papi L, Giannini G, Palli D and Ottini L:
PALB2 mutations in male breast cancer: a population-based study in
Central Italy. Breast Cancer Res Treat. 122:299–301. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Blanco A, de la Hoya M, Balmaña J, Ramón y
Cajal T, Teulé A, Miramar MD, Esteban E, Infante M, Benítez J,
Torres A, Tejada MI, Brunet J, Graña B, Balbín M, Pérez-Segura P,
Osorio A, Velasco EA, Chirivella I, Calvo MT, Feliubadaló L, Lasa
A, Díez O, Carracedo A and Vega A: Detection of a large
rearrangement in PALB2 in Spanish breast cancer families with male
breast cancer. Breast Cancer Res Treat. 132:307–315. 2012.
View Article : Google Scholar
|
|
18
|
Breast Cancer Linkage Consortium.
Pathology of familial breast cancer: differences between breast
cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases.
Lancet. 349:1505–1510. 1997. View Article : Google Scholar
|
|
19
|
Tischkowitz M, Xia B, Sabbaghian N,
Reis-Filho JS, Hamel N, Li G, van Beers EH, Li L, Khalil T,
Quenneville LA, Omeroglu A, Poll A, Lepage P, Wong N, Nederlof PM,
Ashworth A, Tonin PN, Narod SA, Livingston DM and Foulkes WD:
Analysis of PALB2/FANCN-associated breast cancer families. Proc
Natl Acad Sci USA. 104:6788–6793. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
den Dunnen JT and Antonarakis SE: Mutation
nomenclature. Curr Protoc Hum Genet. Chapter 7(Unit 7): 132003.
View Article : Google Scholar
|
|
21
|
Apostolou P and Fostira F: Hereditary
breast cancer: the era of new susceptibility genes. Biomed Res Int.
2013:7473182013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Erkko H, Xia B, Nikkilä J, Schleutker J,
Syrjäkoski K, Mannermaa A, Kallioniemi A, Pylkäs K, Karppinen SM,
Rapakko K, Miron A, Sheng Q, Li G, Mattila H, Bell DW, Haber DA,
Grip M, Reiman M, Jukkola-Vuorinen A, Mustonen A, Kere J, Aaltonen
LA, Kosma VM, Kataja V, Soini Y, Drapkin RI, Livingston DM and
Winqvist R: A recurrent mutation in PALB2 in Finnish cancer
families. Nature. 446:316–319. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rahman N, Seal S, Thompson D, Kelly P,
Renwick A, Elliott A, Reid S, Spanova K, Barfoot R, Chagtai T,
Jayatilake H, McGuffog L, Hanks S, Evans DG and Eccles D; Breast
Cancer Susceptibility Collaboration (UK). Easton DF and Stratton
MR: PALB2, which encodes a BRCA2-interacting protein, is a breast
cancer susceptibility gene. Nat Genet. 39:165–167. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zheng Y, Zhang J, Niu Q, Huo D and Olopade
OI: Novel germline PALB2 truncating mutations in African American
breast cancer patients. Cancer. 118:1362–1370. 2012. View Article : Google Scholar
|
|
25
|
Cao AY, Huang J, Hu Z, Li WF, Ma ZL, Tang
LL, Zhang B, Su FX, Zhou J, Di GH, Shen KW, Wu J, Lu JS, Luo JM,
Yuan WT, Shen ZZ, Huang W and Shao ZM: The prevalence of PALB2
germline mutations in BRCA1/BRCA2 negative Chinese women with early
onset breast cancer or affected relatives. Breast Cancer Res Treat.
114:457–462. 2009. View Article : Google Scholar
|
|
26
|
Balia C, Sensi E, Lombardi G, Roncella M,
Bevilacqua G and Caligo MA: PALB2: a novel inactivating mutation in
a Italian breast cancer family. Fam Cancer. 9:531–536. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Papi L, Putignano AL, Congregati C,
Piaceri I, Zanna I, Sera F, Morrone D, Genuardi M and Palli D: A
PALB2 germline mutation associated with hereditary breast cancer in
Italy. Fam Cancer. 9:181–185. 2010. View Article : Google Scholar
|
|
28
|
Zhang F, Ma J, Wu J, Ye L, Cai H, Xia B
and Yu X: PALB2 links BRCA1 and BRCA2 in the DNA-damage response.
Curr Biol. l19:524–529. 2009. View Article : Google Scholar
|
|
29
|
Buisson R, Dion-Côté AM, Coulombe Y,
Launay H, Cai H, Stasiak AZ, Stasiak A, Xia B and Masson JY:
Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in
stimulating homologous recombination. Nat Struct Mol Biol.
17:1247–1254. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dray E, Etchin J, Wiese C, Saro D,
Williams GJ, Hammel M, Yu X, Galkin VE, Liu D, Tsai MS, Sy SM,
Schild D, Egelman E, Chen J and Sung P: Enhancement of RAD51
recombinase activity by the tumor suppressor PALB2. Nat Struct Mol
Biol. 17:1255–1259. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bleuyard JY, Buisson R, Masson JY and
Esashi F: ChAM, a novel motif that mediates PALB2 intrinsic
chromatin binding and facilitates DNA repair. EMBO Rep. 13:135–141.
2012. View Article : Google Scholar
|
|
32
|
Southey MC, Southey MC, Teo ZL and Winship
I: PALB2 and breast cancer: ready for clinical translation! Appl
Clin Genet. 6:43–52. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Vietri MT, Molinari AM, Laura De Paola M,
Cantile F, Fasano M and Cioffi M: Identification of a novel
in-frame deletion in BRCA2 and analysis of variants of BRCA1/2 in
Italian patients affected with hereditary breast and ovarian
cancer. Clin Chem Lab Med. 50:2171–2180. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pern F, Bougdanova N, Schurmann P, Lin M,
Ay A, Langer F, Hillemanns P, Christiansen H, Park-Simon TW and
Dörk T: Mutation analysis of BRCA1, BRCA2, PALB2 and BRD7 in a
hospital-based series of German patients with triple negative
breast cancer. PLoS One. 7:e479932012. View Article : Google Scholar
|
